Pegfilgrastim biosimilar (Cinfa Biotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegfilgrastim biosimilar (Cinfa Biotech)
Drug Alias NamePegfilgrastim生物仿制药Pegylated granulocyte colony stimulating factor-Cinfa Biotechpegfilgrastim biosimilarPegfilgrastim生物类似药Pelmeg +[6] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2018/11/20
Country/TerritoryGermanyEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCinfa Biotech Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesMundipharma Corporation (Ireland) Ltd
Inactive CompaniesCinfa Biotech Gmbh
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA13
Related LinksN/A